MENU

Medical Marijuana and CBD: Expanding Acceptance and Use by Physicians

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Owner/Physician Advanced Pain and Rehab specialists and Beyond Biome
    Biography

      Dr. Anu Anand is a board certified specialist in Physical Medicine and Rehabilitation ("PM&R").  Dr. Anand practices in Pittsburgh in her own private practice managing patients in skilled nursing facilities and acute care settings. She is also on staff at Encompass Rehab Hospital. Prior to this she worked in private practice in outpatient clinics as well as acute inpatient rehab. Dr. Anand was part of a PM&R medical practice in Queens, New York, before her move to Pittsburgh.



      Dr. Anand’s experience comprises various specialties of PM&R, including EMGs, spasticity control with Botox injections and Baclofen pump refills, and pain management with joint and trigger point injections. Dr. Anand is also proficient with prosthetics and orthotics as well as ultrasound for diagnosis and injections.



      Dr. Anand completed her residency in PM&R at Nassau University Medical Center in New York as well as a one year general surgery internship at Montefoire Medical Center in New York. Dr. Anand is a graduate of AUC Medical School, and received degrees in Biology and Economics from the University of Michigan.



      Dr. Anand has been a contributing author to multiple PM&R books and publications.  She is Pennsylvania state approved medical marijuana provider, has certification in migraine management with Botox, and has a certification from the American Academy of Brain Injury Specialist. Her practice focuses on helping patients achieve their best possible physical function and obtaining the best quality of life.



      In recent years Dr. Anand has developed an interest in alternative pain management due to the opioid epidemic. She has been an approved PA medical marijuana provider and recently started her own line of science backed CBD products based on research and patient feed back in her pain management clinic.


    Abstract

    Over the past few years there has been an increased interest in the role of cannabis for treating medical conditions. Attitude towards cannabis has evolved rapidly with the expanding legalization of hemp and medical and recreational marijuana across various states. The variability of cannabis and hemp based products, along with limited research due to schedule 1 classification of marijuana and CBD in the United States has restricted medical professionals' understanding and acceptance of these products for patient use.  These shifts in cannabis use require clinicians to understand conflicting laws, health implications, and therapeutic possibilities. An adequate understanding of both legal and clinical issues is essential for optimal intervention.

    Learning Objectives:

    1. Learn of potential benefits of marijuana and CBD for patients

    2. Be familiar with possible adverse effects and drug interactions

    3. To review the current evidence and consider additional research needed to support the therapeutic use of THC and CBD


    Show Resources
    You May Also Like
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    APR 19, 2021 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    APR 19, 2021 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: Apri 19, 2021 Time: 8:00am PDT, 5:00pm CEST Since the inception of modern biological research, BioSafety has evolved into a critical consideration in Good Laboratory Practices (GLP). Wi...
    JAN 21, 2021 8:00 AM PST
    JAN 21, 2021 8:00 AM PST
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    Loading Comments...
    Show Resources
    Attendees
    • See more